SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines.
Saved in:
| Title: | SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines. |
|---|---|
| Authors: | Dominguez Islas CP; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Magaret CA; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Molitor C; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Castro M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Posavad CM; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Atmar RL; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA., Janes H; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. Electronic address: hjanes@fredhutch.org., Deming ME; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. |
| Source: | Vaccine [Vaccine] 2025 Oct 24; Vol. 65, pp. 127738. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41027157 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dominguez+Islas+CP%22">Dominguez Islas CP</searchLink>; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Magaret+CA%22">Magaret CA</searchLink>; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Molitor+C%22">Molitor C</searchLink>; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Serebryannyy+L%22">Serebryannyy L</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Narpala+S%22">Narpala S</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Castro+M%22">Castro M</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Posavad+CM%22">Posavad CM</searchLink>; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+PC%22">Roberts PC</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lyke+KE%22">Lyke KE</searchLink>; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Atmar+RL%22">Atmar RL</searchLink>; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Janes+H%22">Janes H</searchLink>; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. Electronic address: hjanes@fredhutch.org.<br /><searchLink fieldCode="AU" term="%22Deming+ME%22">Deming ME</searchLink>; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 Oct 24; Vol. 65, pp. 127738. <i>Date of Electronic Publication: </i>2025 Sep 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41027157 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2025.127738 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127738 Titles: – TitleFull: SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dominguez Islas CP – PersonEntity: Name: NameFull: Magaret CA – PersonEntity: Name: NameFull: Molitor C – PersonEntity: Name: NameFull: Serebryannyy L – PersonEntity: Name: NameFull: Narpala S – PersonEntity: Name: NameFull: Castro M – PersonEntity: Name: NameFull: Posavad CM – PersonEntity: Name: NameFull: Roberts PC – PersonEntity: Name: NameFull: Lyke KE – PersonEntity: Name: NameFull: Atmar RL – PersonEntity: Name: NameFull: Janes H – PersonEntity: Name: NameFull: Deming ME IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 10 Text: 2025 Oct 24 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 65 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |